ERBB2 and breast cancer: Breast cancer is the most common cancer as per Saudi Cancer registry 2015 with total number of newly diagnosed breast cancer cases of 2016.[26] Around 25% breast cancer patients are human epidermal growth factor receptor 2 (her2neu) positive and need trastuzumab.